87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT
Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and
Natural killer cells offer hope for hard-to-treat pediatric sarcomas

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025
Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while
Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me
Survival rates for incurable larynx cancer investigated for first time

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it
Scientists develop scans that light up aggressive cancer tumors for better treatment

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1
New microscopy technique could enable rapid tumor analysis in the operating room

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t